Loading data
MBXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Research and development expense | 79.16 m USD | 57.42 m USD | 28.53 m USD |
| Operating profit | -98.06 m USD | -68.19 m USD | -35.31 m USD |
| Profit before tax | -87 m USD | -61.9 m USD | — |
| Income tax expense | 0 USD | 0 USD | — |
| Net income (reported basis) | -87 m USD | -61.9 m USD | -32.6 m USD |
| Net income attributable to common shareholders | -86.97 m USD | -61.92 m USD | -32.56 m USD |
| Basic earnings per share | -2.38 USD/share | -5.82 USD/share | -31.96 USD/share |
| Diluted earnings per share | -2.38 USD/share | -5.82 USD/share | -31.96 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.